Recent studies have identified decreased Dio3os expression in hepatocellular carcinoma, thyroid carcinoma, and non-small cell lung cancer but abnormally increased in breast cancer [20] and pancreatic cancer [19]. This evidence concerns the gene DIO3OS and thyroid gland carcinoma.